Applied BioCode, Inc. develops, manufactures, and commercializes multiplex diagnostic testing products. The company's products focus on the $4.5 billion molecular diagnostic infectious disease segment of the market with assays that detect pathogens for gastrointestinal infections, respiratory infections and other high value diseases. Also included are the infectious disease, autoimmune disease, allergy, gut microbiome, and veterinary diagnostics markets.